1. Increased CCL22 expression in psoriatic skin predicts a good response to infliximab therapy. (1st November 2014) Authors: Kusumoto, S.; Kajihara, I.; Nagamoto, E.; Makino, K.; Ichihara, A.; Aoi, J.; Johno, T.; Makino, T.; Fukushima, S.; Jinnin, M.; Ihn, H. Journal: British journal of dermatology Issue: Volume 171:Number 5(2014:Nov.) Page Start: 1259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Increased CCL22 expression in psoriatic skin predicts a good response to infliximab therapy. (22nd October 2014) Authors: Kusumoto, S.; Kajihara, I.; Nagamoto, E.; Makino, K.; Ichihara, A.; Aoi, J.; Johno, T.; Makino, T.; Fukushima, S.; Jinnin, M.; Ihn, H. Journal: British journal of dermatology Issue: Volume 171:Number 5(2014:Nov.) Page Start: 1259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Increased CCL22 expression in psoriatic skin predicts a good response to infliximab therapy. (22nd October 2014) Authors: Kusumoto, S.; Kajihara, I.; Nagamoto, E.; Makino, K.; Ichihara, A.; Aoi, J.; Johno, T.; Makino, T.; Fukushima, S.; Jinnin, M.; Ihn, H. Journal: British journal of dermatology Issue: Volume 171:Number 5(2014:Nov.) Page Start: 1259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗